Global Auto-Injectors Market Analysis, Drivers, Restraints, Opportunities, Trends, and Growth Forecast to 2027

MarketResearch.biz, in its upcoming report titled, “Global Auto-injectors Market Trends, Applications, Analysis, Growth, and Forecast to 2027”, offers in-depth insights, revenue details, and other vital information regarding the global auto-injectors market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report also offers insightful and detailed information regarding the various key players operating in the global auto-injectors market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global auto-injectors market was valued at nearly US$ X, XXX million in 2016. The market is anticipated to register a CAGR of XX.X% during the forecast period and is projected to be valued at nearly US$ X, XXX million by the end of 2026. The global auto-injectors market has been segmented on the basis of product, design, application, and region.

Auto-injectors are medical devices designed for delivering a fixed dose of particular drug and are intended for self-administration by patients. Auto-injectors are gradually gaining demand for treating various indications such as anaphylaxis, multiple sclerosis, rheumatoid arthritis and others. Most auto-injectors are spring-loaded syringes, which make the procedure relatively simple. These instruments are specially made to avoid needle stick injury, anxiety, blood clots, and needle phobia among patients. The location for injecting a particular drug is dependent on the nature of the drug, however it is normally taken through any intramuscular route.

Factors driving growth of the global auto-injectors market includes rising incidences of anaphylactic shock, rising awareness of patients about auto-injectors coupled with rising preference for self-administration of injections. Auto-injectors provide inexpensive home medication, reduce dependency on healthcare professionals and time consumed at in-patient and out-patient care units, thereby fueling growth of the global auto-injectors market. In addition, factors such as rising geriatric population and high production of biologics are also contributing to growth of the global auto-injectors market.

Despite various advantages of auto-injectors, high prices of these injectors and availability of substitute products such as general injections and oral tablets may hamper growth of this market in the near future.

North America is largest market for auto-injectors owing to increasing diabetes and anaphylaxis cases, and increasing production of biologics. The auto-injectors market is expected to witness fastest growth in Asia Pacific during the forecast period owing to increasing cases of anaphylaxis, increasing awareness about needle-stick injuries, rising healthcare expenditure, and growing geriatric population.

Global auto-injectors market segmentation by product:

• Prefilled
• Fillable

Global auto-injectors market segmentation by design:

• Standardized
• Customized

Global auto-injectors market segmentation by application:

• Anaphylaxis
• Multiple Sclerosis
• Rheumatoid Arthritis
• Others

Global auto-injectors market segmentation by distribution channels:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores

Global auto-injectors market segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Mylan N.V.
• Antares Pharma Inc.
• Becton, Dickinson & Co.
• Eli Lilly and Company
• Pfizer, Inc.
• Bayer AG
• Novartis International AG
• Bristol-Myer Squibb
• Amgen Inc.
• Biogen Inc.